Providing community-based health practitioners with timely and accurate discharge medicines information by Alice V Gilbert et al.
Gilbert et al. BMC Health Services Research 2012, 12:453
http://www.biomedcentral.com/1472-6963/12/453RESEARCH ARTICLE Open AccessProviding community-based health practitioners
with timely and accurate discharge medicines
information
Alice V Gilbert1*, Bhavini Patel1, Melanie Morrow1, Desmond Williams2, Michael S Roberts3 and Andrew L Gilbert2Abstract
Background: Accurate and timely medication information at the point of discharge is essential for continuity of
care. There are scarce data on the clinical significance if poor quality medicines information is passed to the next
episode of care. This study aimed to compare the number and clinical significance of medication errors and
omission in discharge medicines information, and the timeliness of delivery of this information to community-based
health practitioners, between the existing Hospital Discharge Summary (HDS) and a pharmacist prepared Medicines
Information Transfer Fax (MITF).
Method: The study used a sample of 80 hospital patients who were at high risk of medication misadventure, and
who had a MITF completed in the study period June – October 2009 at a tertiary referral hospital. The medicines
information in participating patients’ MITFs was validated against their Discharge Prescriptions (DP). Medicines
information in each patient’s HDS was then compared with their validated MITF. An expert clinical panel reviewed
identified medication errors and omissions to determine their clinical significance. The time between patient
discharge and the dispatching of the MITF and the HDS to each patient’s community-based practitioners was
calculated from hospital records.
Results: DPs for 77 of the 80 patients were available for comparison with their MITFs. Medicines information in 71
(92%) of the MITFs matched that of the DP. Comparison of the HDS against the MITF revealed that no HDS was
prepared for 16 (21%) patients. Of the remaining 61 patients; 33 (54%), had required medications omitted and 38
(62%) had medication errors in their HDS. The Clinical Panel rated the significance of errors or omissions for 70
patients (16 with no HDS prepared and 54 who’s HDS was inconsistent with the validated MITF). In 17 patients the
error or omission was rated as insignificant to minor; 23 minor to moderate; 24 moderate to major and 6 major to
catastrophic. 28 (35%) patients had their HDS dispatched to their community-based practitioners within 48 hours
post discharge compared to 80 (100%) of MITFs.
Conclusion: The MITF is an effective approach for the timely delivery of accurate discharge medicines information
to community-based practitioners responsible for the patient’s ongoing care.
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Accurate and timely information on medication manage-
ment along the continuum of care is essential to achiev-
ing best outcomes for patients and for avoiding harm
[1-4]. Approximately 3% of hospital admissions occur
due to medication-related problems [5]. Often these pro-
blems are due to miscommunication regarding the con-
tinuation/discontinuation of medications on hospital
discharge [5]. The interface between hospital and the
community care is a high risk area for medication mis-
adventure [5-7].
The Australian Pharmaceutical Advisory Council
(APAC), a Federal Government appointed, multidiscip-
linary council, has attempted to address these issues by
preparing Guiding Principles for Achieving the Con-
tinuum of Medication Management [8]. The Guiding
Principles state that “Health service managers and health
care professionals are jointly and individually account-
able for making sure that activities to support the con-
tinuity of medication management are implemented.” (8,
page 17). The Guiding Principles also reinforce the re-
sponsibility of health professionals to work in partner-
ship with patients in all aspects of medication
management [8]. Similarly, the Society of Hospital Phar-
macists of Australia’s (SHPA) Standards of Practice for
the provision of medication reconciliation require that
“when a patient is transferred to another episode of care
the transferring health professional should supply com-
prehensive, complete and accurate information to the
health care provider responsible for continuing the con-
sumer’s medication management.” ([9], page 2). Con-
tinuity of care between hospitals and the community
sector is a key element in Australia’s Health Care
Reforms [10], and the Federal Government has provided
extra funding for hospitals conditional on implementa-
tion of the Guiding Principles.
The need for high quality clinical handover is exagger-
ated in the Northern Territory (NT) of Australia: It cov-
ers a large geographic area and it has a relatively small,
transient, widely distributed and remote population (n =
225900): 30% of the NT population is Aboriginal and
Torres Strait Islanders (ATSI)a. The life expectancy for
male ATSI is 61.5 years, 17 years less than non-
indigenous males, and for female ATSI 69.2 years,
13 years less than non-indigenous females. The median
age at death of ATSI males is 50 years. [11] Many issues,
including low health literacy, [12] differing cultural
beliefs about health and illness, access to health services
and availability of health professionals limit people’s abil-
ity to access and navigate their way through the complex
health system. The majority of health services are
accessed through health centres based in remote com-
munities. The case mix at the study hospital differs from
other large Australian hospitals; patients are youngerand presentations for trauma and severe sepsis are
higher. The Emergency Department sees approximately
60000 patients per year, ATSI account for 30% of attend-
ance and 50% of admissions. It should be noted that in
this study, patients at high risk of medication misadven-
ture were selected. Nearly half of those selected were
ATSI and their average age was 58 years; 15 years
younger than the rest of the study cohort (See Table 1).
The current discharge procedure at the study hospital
requires an intern or registered medical officer to
complete an electronic Hospital Discharge Summary
(HDS). The HDS contains a section documenting
changes to medications and provides a list of discharge
and continuing medicines. The hospital provides the
HDS to the patient’s general medical practitioner (GP),
aged-care facilities, remote area clinics, or the patient
once the HDS has been completed.
Evidence indicates that a patient in an urban area will
visit their pharmacy within 10 days and their doctor 30 days
after discharge [13]. While most GPs are provided with a
discharge summary, community pharmacists are rarely pro-
vided with this information and patients are not encour-
aged to notify their community-based practitioners of
recent hospitalisations and changes to their medicines. [13]
In this study, the MITF was delivered to medical practi-
tioners, community pharmacists and remote area clinic
staff.
Clinical pharmacists from the study hospital had
reported frequent contacts from community-based prac-
titioners seeking clarification of the medicines informa-
tion provided in the HDS. They also identified that the
length of time for the provision of the HDS to the
patient’s community-based practitioners was outside of
hospital guidelines of 48 hours. In response to this infor-
mation, pharmacists at the study hospital developed a
Medicines Information Transfer Fax (MITF).
This study compares the number and clinical signifi-
cance of medication errors and omissions in, and the
timeliness of delivery of, discharge medicines informa-
tion provided to community-based health professionals
in the existing Hospital Discharge Summary (HDS) and
the Medicines Information Transfer Fax (MITF).
Method
The study was conducted using a convenience sample of
80 MITF’s prepared for patients at high risk of medica-
tion misadventure during a four month period June
2009 – October 2009. At the time the study was con-
ducted there were 9 clinical pharmacists employed in
the hospital and 1000 discharges/week. The clinical
pharmacists selected patients for whom they developed
a MITF based on their assessment of those most at risk
of medication misadventure post discharge. On average
30 MITFs were completed each week. The project team
Table 1 Patient characteristics
Aboriginal and Torres strait islanders
(n = 37)
Non-Aboriginal and Torres strait
islanders (n = 43)
All patients
(n = 80)
Mean age (years), (Range) 58 (33–78) 73 (29–97) 66.1 (29–97)
Gender (Female), n (%) 16 (43%) 19 (44%) 17.6 (43.5%)
Mean number of Medical Conditions (range) 7.4 (3-18) 7.3 (2-12) 7.3 (2-18)
Mean number of medication on discharge (range) 8.6 (3-16) 9.4 (3–23) 9.1 (3–23)
Mean number of changes on Discharge (range) 3 (0–8) 4 (1-13) 3.5 (0–13)
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pleted within the study period because of filing systems
adopted by individual pharmacists; for example some
filed their MITF’s on a monthly basis, and the hospital,
for example storing DP off-site as part of their record
archiving process. The sample of 80 represented 20% of
available MIFTs and was considered sufficient to identify
significant differences, if they existed, between the
current HDS and the MITF.
High risk patients were defined as; those taking mul-
tiple medications, those who had medication changes
during admission, those suspected of poor adherence,
those taking high risk or complex medications and those
with multiple medical conditions. They had a medication
history and reconciliation conducted for the admission
and at the point of discharge as part of standard care.
The reconciled Discharge Prescription (DP) was used to
complete a MITF which also included a complete list of
discharge medications and provided information on any
medication-related changes that occurred during the ad-
mission. MITFs were faxed to the patient’s GP or Re-
mote Medical Officer and community pharmacist at the
time of the patients discharge. The date of sending the
MITF was recorded on the faxed document and filed in
the pharmacy department. The aim was to have the
MITF delivered to the patient’s community-based practi-
tioners within 48 hours of discharge. The time to deliv-
ery of the HDS was calculated using the study hospital’s
admission and discharge software.
Two members of the project team audited the MITF
against the gold standard, the DP. The DP was consid-
ered gold standard as it had been reconciled by a clinical
pharmacist as part of the routine hospital medicines rec-
onciliation process. Medicines information contained in
the HDS was compared with that in the validated MITF.
Medication errors in the HDS were categorised into five
classes; wrong dose, wrong medication, wrong strength,
wrong dose frequency or wrong dose form. Omissions
were also documented (Figure 1: Audit flow chart).
Medication errors and omissions identified in the
audits were reviewed for their clinical significance by a
panel of three senior clinical pharmacists. Panel mem-
bers were blinded to the patient’s name and the name of
the pharmacist who had prepared the MITF. Clinicalsignificance was determined from information on the
patient’s health status and the accuracy and quality of in-
formation provided at discharge. Prior to the review ad-
vice was sought by the panel from the hospital’s liaison
GP to gain insight into how a community-based pre-
scriber would interpret the medication information. For
example if medications were omitted from the HDS, the
advice given to the panel was that a medical practitioner
would interpret this as there being no change to current
medication and would continue the patient’s pre-
hospitalisation medicines, unless deemed clinically in-
appropriate. Each panel member rated the clinical sig-
nificance of each error or omission independently using
the “consequence or impact scale” of the SHPA assess-
ment of intervention tool [14].The five point Likert scale
ranged from 1 (insignificant), 2 (minor), 3 (moderate),
4 (major) to 5 (catastrophic). The overall agreement be-
tween the three assessors was measured using the Kappa
statistic [15].
Results
Of the 80 patients whose MITFs were selected for this
study, three patient’s did not have a DPs available for
comparison. Of the 77 MITFs with DPs available: 6 (8%)
MITFs had errors; Four errors were rated by the clinical
panel as “insignificant to minor” and two errors were
viewed as “minor to moderate”.
A completed HDS was available for 61 (79%) of the 80
patients within the audit time frame; these were com-
pared with the validated MITFs. Seven of the 61 (11%)
HDS’s were consistent with the MITF; 149 medication
omissions and 100 errors were identified in the
remaining 54 HDS’s. An omission occurred when a
medication appeared on the discharge prescription but
was not documented in the HDS. Errors were cate-
gorised into five classes; wrong dose (29, 29%), wrong
medication (23, 23%), wrong strength (20, 20%), wrong
dose frequency (19, 19%) or wrong dose form (9, 9%).
The clinical panel members independently rated the
clinical significance for the 70 patients who had errors
or omissions in their HDS’s or had no HDS completed.
Based on advice from the hospital’s liaison GP, patients
with no HDS completed were reviewed for their clinical
risk associated with no information being provided at
Figure 1 Audit flow chart.
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clinical significance was “insignificant to minor”; 23
(33%) “minor to moderate”; 24 (34%) “moderate to
major” and 6 (9%) were “major to catastrophic” (See
Table 2).
Analysis of the individual panel member’s ratings of
clinical significance indicated a satisfactory level of inter-
rater agreement (Kappa for overall agreement = 0.7).
The HDS was dispatched to 28 (35%) patient’s health-
care providers within the study hospital’s guideline of
48 hours; 38 (47%) were sent within seven days and 55(69%) were sent within 30 days: 25 (31%) HDSs had not
been dispatched after 30 days post discharge. All MITFs
were dispatched within 48 hours post-discharge.
Discussion
Despite national guidelines, extensive research, the avail-
ability of funding for more pharmacists to implement the
APAC guiding principles for the continuum of care and
professional practice standards related to clinical hand-
over, medication management along the continuum of
care is still problematic. This audit of the current




Insignificant to minor 84 year old non-indigenous male discharged after treatment for community acquired pneumonia. Past medical history
includes; fractured neck of femur, urinary incontinence, chronic cardiac failure, atrial fibrillation, and gastro oesophageal
reflux disease. Changes to medication during admission included commencing digoxin, and ceasing Bisoprolol,
spironolactone, and ramipril.
Pharmacist had incorrect dosing for omeprazole on MITF. Omeprazole 40 mg nocte on discharge prescription and
20 mg BD in the MITF all other medication information was transferred correctly on MITF. Insignificant risk to patient.
Minor to moderate 75 year old indigenous male discharged after being admitted for shortness of breath due to worsening chronic cardiac
failure. Past medical history includes; chronic obstructive airways disease (current smoker), atrial fibrillation, chronic
cardiac failure, myocardial infarction and hypertension. During admission frusemide was increased from 40 mg mane to
60 mg mane.
All medications were omitted in the HDS, therefore from advice from the hospital’s liaison GP assumed all medications
and doses were continued. Primary health care professional would not be aware of increase in frusemide dose therefore
minor risk to patient of deterioration and potential re-admission.
Moderate to major 55 year old non-indigenous male discharged post an episode of chest pain on the back ground of high risk cardiac
disease. Past medical history includes; ST segment elevation myocardial infarction, severe arterial stenosis (ischaemic
heart disease), asthma, and transient ischaemic attack. Patient was discharged after an increase in nicorandil from 5 mg
BD to 10 mg BD and an increase in Isosorbide mononitrate from 60 mg mane to 90 mg mane.
This patient did not have HDS completed. Therefore is a moderate risk that this patient will be re-admitted due to
reverting back to original dosing and increasing angina attacks. Also risk of confusion of medications to patient.
Major to catastrophic 37 year old indigenous female discharged with osteomyelitis. Past medical history of end stage renal disease (on
dialysis), chronic intermittent vomiting since starting dialysis which has been fully investigated, type 2 diabetes,
hypertension, dyslipidaemia, and a previous right toe amputation with residual osteomyelitis.
During admission diabetic control was reviewed and changed by increasing insulin dose from 10 units nocte to 14
units nocte and metformin XR 500 mg mane was ceased.
Osteomylitis treatment was changed by ceasing Trimethoprim/ Sulphamethoxazole 160/800 mg BD and folic acid 5 mg
and commencing on Doxycycline 100 mg mane and ciprofloxacin 500 mg nocte for lifelong treatment.
Metformin XR 500 mg was included in HDS (it had been ceased during admission) with new dose of insulin correct,
therefore putting patient at risk of hypoglycaemia.
Doxycycline and ciprofloxacin had been omitted from HDS therefore primary health care provider would not be aware
of change to antibiotic regime. High risk of further amputations and losing foot due to osteomyelitis infection.
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the accuracy, quality and timeliness of delivery of the HDS
to community-based practitioners responsible for the next
episode of care. Studies from Europe, North America and
New Zealand have produced similar results [1-4].
Our analysis of the clinical significance of medication
errors or omissions in the HDS, based on information
on the patient’s health status, and the accuracy and qual-
ity of information provided at discharge revealed signifi-
cant risks to patient’s well-being. An alarming 43% of
medication errors or omissions discovered in our review
on 80 HDS were rated as moderate to catastrophic.
While our findings are also consistent with previous
Australian studies [5,6,16], the context in which these
errors and omissions occur adds extra cause for concern.
Nearly 50% of patients in this audit were Aboriginal or
Torres Strait Islanders (ATSI) and clinical handover was
often to remote area health services. The lack of a dis-
charge summary, or errors and omissions in the dis-
charge medicines information provided, may be even
more significant because of poorer health status, low
health literacy [12] and the low access to medical practi-
tioners and community pharmacy services [17,18]. Manyadult ATSI patients have multiple chronic health pro-
blems at a much younger age than non-indigenous
people. Over 35% will have diabetes, often coupled with
other chronic conditions such as mental health pro-
blems, arthritis and cardiovascular disease [11,19]. Medi-
cines management is consequently complex, with
multiple medications in use.
The study hospital’s current policy for discharging
patients with only 7 days of medications, with an option
of an increased supply for patients returning to a remote
community, may exacerbate many of the problems iden-
tified in this audit. This may have significant health con-
sequences, when people with multiple chronic health
problems visit their community pharmacist, health clinic
or medical practitioner, if accurate information on medi-
cation changes associated with the hospitalisation are
not available within this timeframe. Findings of this
study indicate that only 47% of HDSs were delivered
within 7 days from discharge.
Due to work load and time restraints the clinical phar-
macists only focused on high risk patients. The ability of
the clinical pharmacists’ to deliver an accurate and high
quality medication discharge process, with timely
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health practitioners involved in the next episode of care
was demonstrated in this project.
The time is right for a new model for the hospital dis-
charge process. Guidance for hospital and community
pharmacists to support patient discharge from hospital
has recently been published by the United Kingdom Na-
tional Prescribing Centre [20]. The guidance aims to fos-
ter relationships between community pharmacists and
hospital staff. In Australia, new funding is expected to
be available for hospital pharmacists, GP’s and commu-
nity pharmacists to deliver a comprehensive medicines
discharge process, including a Hospital Initiated Home
Medicines Review [21]. Developing the relationships be-
tween community pharmacists, hospital pharmacists,
medical practitioners, health clinic staff and engaging
patients, will be critical success factors.
Limitations were identified while conducting this
study. Pharmacists prioritised patients with complex
medication-related issues for a MITF. These patients
have many, and often “last minute” changes to their
medications near discharge, making it difficult for those
completing the HDS to accurately complete the dis-
charge medication record. Further, medical practitioners
in the hospital were not asked about how they make
decisions about information to be included in their
HDS. They may, for example, concentrate more on ac-
curate recording of diagnoses, expecting pharmacists
and nurses to ensure accurate recording of medication
changes. Whilst the hospital’s liaison GP was asked for
assistance when the clinical panel was rating the signifi-
cance of omitted medicines, not having prescribers
represented on the panel was a limitation that should be
rectified in subsequent audits. The usefulness of infor-
mation contained in the MITF has not been formally
tested by requesting feedback from the community-
based practitioners. There is the likelihood of confusion
if a community-based practitioner received conflicting
information from the hospital, as may be the case when
the HDS and the MIFT have different medication man-
agement information. This may increase time demands
on the community-based practitioners as they will need
to contact the hospital to clarify discrepancies. Finally
the small sample size was determined by the capacity of
the research team to undertake this study while main-
taining a full-time case load and other professional re-
sponsibilities. The magnitude of the issues uncovered,
even with this small sample size, has meant however
meaningful conclusions can be drawn.
Notwithstanding these limitations, this simple inno-
vation has identified significant issues with the existing
HDS and has demonstrated that the MITF delivered ac-
curate, timely and complete handover of medication
management information from the hospital serviceproviders to community-based practitioners. The study
was led by clinical pharmacists working full-time in the
hospital. Its success is an important example of the use-
fulness of imbedded practitioner research methods [22].
Being imbedded in the setting means that the research-
ers knew from conversations about the limitations of the
HDS, the frustrations caused to community–based prac-
titioners and the risk to patients when they had no dis-
charge information or when the information provided
was not correct. The researchers also knew about the
hospitals culture and what was possible in terms of en-
gagement of other health workers in the study, work
force capacity and pathways to implement change based
on the study results.
The promise of an information technology (IT) solu-
tion to the problem of timely and accurate clinical hand-
over has not yet been realised. In the NT alone there are
at least five different IT patient administration systems
(for example primary care information systems, remote
area information systems, GP prescribing software and
pharmacy dispensing software) that need to be nego-
tiated in what is a highly transient population group.
The MITF provides an ideal interim measure for consid-
eration as electronic support for discharge processes are
implemented.
The results reported in this paper relate only to the
introduction period of the MITF in 2009. Based on the
data generated in the study, the MITFs are now required
to be completed by all pharmacists as part of their daily
duties. The MITF template has also been adopted by
four of the five hospitals in the NT (the remaining hos-
pital does not have a pharmacist). Training in the com-
pletion of the MITF is now also fully integrated into the
orientation process for new pharmacists to the NT hos-
pital Network. The MITF template is currently being
mapped by the programmers of the electronic based
hospital discharge software to provide the capability for
prescribers to examine and utilise the information avail-
able in the MIFT at the time of creating their HDS.
Conclusion
This study demonstrated increased accuracy, quality and
timeliness of medication information relayed from the
hospital to community-based practitioners through the
use of the MITF. The MIFT provides an excellent plat-
form for further strengthening and standardising the
medicines discharge processes in hospitals. Based on the
results of this study the MITF is now a formal require-
ment of the hospital’s patient discharge processes.
Endnote
a Torres Strait Islanders are the indigenous people of
the Torres Strait Islands, which are a part of Australia.
They are culturally and genetically linked to Melanesian
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being distinct from other Aboriginal peoples from the
rest of Australia.
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